Loading...

Polo Like Kinase 2 Tumour Suppressor and cancer biomarker: new perspectives on drug sensitivity/resistance in cancer

The polo-like kinase PLK2 has recently been identified as a potential theranostic marker in the management of chemotherapy sensitive cancers. The methylation status of the PLK2 CpG island varies with sensitivity to paclitaxel and platinum in ovarian cancer cell lines. Importantly, extrapolation of t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Coley, Helen M., Hatzimichael, Eleftheria, Blagden, Sarah, McNeish, Iain, Thompson, Alastair, Crook, Tim, Syed, Nelofer
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292894/
https://ncbi.nlm.nih.gov/pubmed/22289679
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!